Skip to content
Clinical Trials – home
RomaniaBack to Romania

Clinical trials in Brasov – page 6

179 clinical trials in Brasov, Romania across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

RomaniaOur site in RomaniaStudii.Clinice.ro(opens in a new tab)
Brasov at a glance
179
clinical trials
  • Research sites3
Type of trial
Recruitment status
Quick filters

179 trials in Brasov

Open in trial search

Study on Long-term Safety and Efficacy of Efgartigimod PH20 SC in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Study on the Safety and Effectiveness of Contezolid Acefosamil, Contezolid, and Linezolid for Adults with Moderate or Severe Diabetic Foot Infections

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Aztreonam
  • Sponsor:Micurx Pharmaceuticals Inc.
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:AstraZeneca AB

Study on Human Normal Immunoglobulin and Sodium Chloride to Prevent Infections in Patients with Chronic Lymphocytic Leukemia

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Grifols Therapeutics LLC

Sjogren's syndrome

Not yet recruiting

Phase 3 Randomized, Double‑Blind Study of Telitacicept versus Placebo for Efficacy and Safety in Adults with Active Primary Sjögren’s Disease

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Telitacicept
  • Sponsor:Vor Biopharma Inc.

Atrial fibrillation

Not yet recruiting

Prevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.

Arteriosclerosis

Not yet recruiting

A study to evaluate the effect of muvalaplin on reducing major cardiovascular events in adults with high levels of lipoprotein(a) and atherosclerotic cardiovascular disease.

Investigational
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.

Rheumatoid arthritis

Not yet recruiting

Study comparing MB04 (etanercept biosimilar) with Enbrel in patients with moderate to severe rheumatoid arthritis who are taking methotrexate

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Etanercept
  • Sponsor:Mabxience Research S.L.

Type 2 diabetes mellitus

Not yet recruiting

Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Albiglutide
  • Sponsor:Eli Lilly & Co.

Asthma

Not yet recruiting

Long‑Term Safety and Tolerability Study of Oral KT‑621 in Adults with Uncontrolled Moderate‑to‑Severe Eosinophilic Asthma

InvestigationalNo placebo
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Sponsor:Kymera Therapeutics Inc.

Systemic scleroderma

Not yet recruiting

Safety and Efficacy of MTX-474 in Adults with Diffuse Cutaneous Systemic Sclerosis (dcSSc) – A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study

Registered drug
Countries:RomaniaRomania
  • Participants:18–64 years · 65+ years
  • Substances:Glucose Monohydrate
  • Sponsor:Mediar Therapeutics Inc.

Pyelonephritis acute

Not yet recruiting

Study on Cefepime and Enmetazobactam for Children with Complicated Urinary Tract Infections, Including Acute Pyelonephritis

Registered drugNo placebo
Countries:RomaniaRomania
  • Participants:0–17 years
  • Substances:Cefepime

Other cities in Romania

The busiest research cities in the country

All 65 cities in Romania

Clinical research in Brasov

What the registry says about research in the country

01 Immunology & Infectious Disease

Clinical trials focusing on meningococcal infection prevention and respiratory syncytial virus (RSV) in infants, testing novel vaccines and preventive treatments.

  • Meningococcal ACYW conjugate vaccine studies
  • RSV prevention research
  • Immunogenicity assessment

Research emphasizes safety and efficacy in pediatric populations.

02 Cardiovascular & Metabolic Disorders

Innovative research targeting heart failure prevention and hypertriglyceridemia, exploring new therapeutic approaches.

  • Heart failure risk reduction studies
  • Lipid management trials
  • Cardiovascular outcomes research

Studies focus on both prevention and treatment strategies.

03 Autoimmune Conditions

Comprehensive trials investigating treatments for Myasthenia Gravis, Sjögren's Syndrome, and other autoimmune disorders.

  • Novel therapeutic antibodies
  • Disease-modifying treatments
  • Long-term efficacy studies

Research aims to improve daily living activities and symptom management.

04 Respiratory Medicine

Advanced research in asthma and chronic rhinosinusitis, evaluating innovative treatments and therapeutic approaches.

  • Anti-TSLP antibody studies
  • Nasal polyp treatments
  • Respiratory function improvement

Focus on uncontrolled conditions and symptom management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.